Technical Analysis for BNTC - Benitec Biopharma Limited

Grade Last Price % Change Price Change
grade F 1.51 7.86% 0.11
BNTC closed up 7.86 percent on Wednesday, January 16, 2019, on 29 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical BNTC trend table...

Date Alert Name Type % Chg
Jan 16 Shooting Star Candlestick Bearish 0.00%
Jan 16 Lizard Bearish Bearish Day Trade Setup 0.00%
Jan 16 Crossed Above 20 DMA Bullish 0.00%
Jan 16 Narrow Range Bar Range Contraction 0.00%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 16 Gapped Up Strength 0.00%
Jan 15 Narrow Range Bar Range Contraction 7.86%
Jan 15 Inside Day Range Contraction 7.86%
Jan 15 Wide Bands Range Expansion 7.86%
Jan 14 Wide Bands Range Expansion 7.09%

Older signals for BNTC ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:

Profile
Benitec Biopharma Limited, a biotechnology company, develops novel treatments for chronic and life-threatening conditions based on its gene silencing technology, DNA-directed RNA interference (ddRNAi). The company's ddRNAi technology provides novel therapeutics to treat a range of human medical diseases and conditions, such as hepatitis C, hepatitis B, wet age-related macular degeneration, cancer-associated pain, drug resistant lung cancer, and oculopharyngeal muscular dystrophy (OPMD). Its pipeline of in-house and partnered therapeutic programs include TT-034 for hepatitis C; Tribetarna for the treatment of chemotherapy resistant non-small cell lung cancer; Hepbarna for Hepatitis B; and Pabparna for the treatment of OPMD. The company also licenses its ddRNAi technology to biopharmaceutical companies for the clinical applications comprising HIV/AIDS, retinitis pigmentosa, and Huntington's disease. Benitec Biopharma Limited was founded in 1997 and is based in Sydney, Australia.
Is BNTC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Dec 24 Midday Gainers / Losers
Dec 24 Savara and CRISPR Therapeutics among healthcare gainers; EyePoint Pharmaceuticals and Novus Therapeutics among losers
Dec 21 Microcaps dominate midday movers
Dec 21 Spectrum Pharmaceuticals among healthcare gainers; TRACON Pharmaceuticals and Perrigo among losers
Dec 21 Benitec Provides Update on BB-401 Cancer Treatment Program
Dec 20 The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum
Dec 11 The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings
Nov 23 Is Benitec Biopharma Limited’s (ASX:BLT) Balance Sheet A Threat To Its Future?
Sep 19 Benitec Biopharma Announces the Appointment of Gregory R. Reyes, M.D., Ph.D. as Senior Scientific Advisor
Sep 5 Gene therapy players under pressure
See more BNTC news...
Indicators
Indicator Value
52 Week High 4.9
52 Week Low 1.01
Average Volume 7,249
200-Day Moving Average 2.4626
50-Day Moving Average 1.8978
20-Day Moving Average 1.4853
10-Day Moving Average 1.436
Average True Range 0.128
ADX 18.99
+DI 28.1829
-DI 29.1155
Chandelier Exit (Long, 3 ATRs ) 1.596
Chandelier Exit (Short, 3 ATRs ) 1.394
Upper Bollinger Band 1.9111
Lower Bollinger Band 1.0595
Percent B (%b) 0.53
BandWidth 57.335218
MACD Line -0.1364
MACD Signal Line -0.1677
MACD Histogram 0.0313
Fundamentals Value
Market Cap 15.49 Million
Num Shares 10.3 Million
EPS -0.52
Price-to-Earnings (P/E) Ratio -2.90
Price-to-Sales 3.15
Price-to-Book 1.63
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.59
Resistance 3 (R3) 1.59 1.57 1.57
Resistance 2 (R2) 1.57 1.55 1.57 1.57
Resistance 1 (R1) 1.54 1.54 1.56 1.54 1.56
Pivot Point 1.52 1.52 1.53 1.52 1.52
Support 1 (S1) 1.49 1.50 1.51 1.49 1.46
Support 2 (S2) 1.47 1.49 1.47 1.45
Support 3 (S3) 1.44 1.47 1.45
Support 4 (S4) 1.44